The reliable detection of circulating tumor cells (CTCs) in metastatic breast cancer (MBC) is
possible by using immunomagnetic separation and subsequent characterization with the …

Background: Metastatic breast cancer (MBC) is incurable and any treatment is considered
palliative. Occult dissemination of tumor cells is responsible for recurrent MBC in patients …

Introduction Circulating tumor cells (CTC) and more recently, CTC clusters are implicated as
a fundamental mechanism by which tumor cells break away from the primary site and travel …

Circulating tumor cells (CTCs) in patients with breast cancer can be regarded as the pre-
stadium of clinically manifest distant metastases. Here we present results on CTCs …

Circulating tumor cells (CTCs) are an independent prognostic factor for patients with
metastatic breast cancer (MBC). However, the role of CTCs in early breast cancer …

The availability of blood-based diagnostic testing using a non-invasive technique holds
promise for real-time monitoring of disease progression and treatment selection. Circulating …

Testing for circulating tumor cells has emerged as a new and promising tool for stratifying
and monitoring patients with metastatic disease. Appropriate risk and biologic stratification in …

To determine the prognostic value of the timing of circulating breast tumour cell
measurement during treatment, peripheral blood from 164 patients with breast disease was …

Opinion statement Breast cancer is the most frequent type of cancer in women with major
cause of death being metastatic disease. Despite aggressive adjuvant systemic therapy with …

Abstract Circulating Tumor Cells (CTC) are shed from primary or secondary tumors. Prior
studies have demonstrated that enumeration of CTC is a robust independent prognostic …